8.79
price up icon1.03%   0.09
after-market Dopo l'orario di chiusura: 8.77 -0.02 -0.23%
loading
Precedente Chiudi:
$8.70
Aprire:
$8.745
Volume 24 ore:
28,572
Relative Volume:
0.18
Capitalizzazione di mercato:
$107.56M
Reddito:
$1.54M
Utile/perdita netta:
$-38.70M
Rapporto P/E:
-1.8822
EPS:
-4.67
Flusso di cassa netto:
$-36.86M
1 W Prestazione:
+3.17%
1M Prestazione:
+11.41%
6M Prestazione:
-18.54%
1 anno Prestazione:
-84.77%
Intervallo 1D:
Value
$8.7332
$8.86
Intervallo di 1 settimana:
Value
$8.37
$9.2272
Portata 52W:
Value
$4.64
$61.90

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile

Name
Nome
Corbus Pharmaceuticals Holdings Inc
Name
Telefono
617-963-0103
Name
Indirizzo
500 RIVER RIDGE DRIVE, NORWOOD, MA
Name
Dipendente
28
Name
Cinguettio
@corbuspharma
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
CRBP's Discussions on Twitter

Confronta CRBP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CRBP
Corbus Pharmaceuticals Holdings Inc
8.79 106.46M 1.54M -38.70M -36.86M -4.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-28 Iniziato William Blair Outperform
2024-12-02 Iniziato Piper Sandler Overweight
2024-07-30 Iniziato Wedbush Outperform
2024-07-22 Ripresa H.C. Wainwright Buy
2024-06-26 Iniziato B. Riley Securities Buy
2024-06-03 Reiterato Oppenheimer Outperform
2024-05-13 Iniziato RBC Capital Mkts Outperform
2024-03-06 Aggiornamento Jefferies Hold → Buy
2020-09-08 Downgrade BTIG Research Buy → Neutral
2020-09-08 Downgrade Jefferies Buy → Hold
2020-09-08 Downgrade RBC Capital Mkts Outperform → Sector Perform
2020-09-08 Downgrade ROTH Capital Buy → Neutral
2020-07-07 Iniziato ROTH Capital Buy
2020-06-17 Iniziato BTIG Research Buy
2020-03-26 Iniziato Nomura Buy
2019-04-05 Iniziato Jefferies Buy
2019-03-20 Iniziato Oppenheimer Outperform
2019-01-11 Reiterato Cantor Fitzgerald Overweight
2018-12-26 Iniziato H.C. Wainwright Buy
2018-12-07 Iniziato RBC Capital Mkts Outperform
2018-10-24 Iniziato B. Riley FBR Buy
2018-01-19 Iniziato Raymond James Outperform
2017-12-14 Reiterato Cantor Fitzgerald Overweight
2017-11-08 Reiterato Noble Financial Buy
2017-09-29 Ripresa Noble Financial Buy
2017-03-30 Reiterato Cantor Fitzgerald Overweight
2016-11-15 Reiterato JMP Securities Mkt Outperform
2016-11-11 Reiterato Noble Financial Buy
Mostra tutto

Corbus Pharmaceuticals Holdings Inc Borsa (CRBP) Ultime notizie

pulisher
Jul 23, 2025

Is Corbus Pharmaceuticals Holdings Inc. a good long term investmentOutstanding stock performance - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Corbus Pharmaceuticals Holdings Inc. stock priceFree Stock Index Interpretation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Corbus Pharmaceuticals Holdings Inc. stock attracts strong analyst attentionElite Stock Shortlist - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Corbus Pharmaceuticals Holdings Inc. Stock Analysis and ForecastMarket-leading profit generation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Corbus Pharmaceuticals Holdings Inc. stockOutstanding yields - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is largely controlled by institutional shareholders who own 51% of the company - Yahoo Finance

Jul 20, 2025
pulisher
Jul 20, 2025

(CRBP) Proactive Strategies - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 18, 2025

why corbus pharmaceuticals holdings inc. stock attracts strong analyst attentionCapital Safe Stock Watchlist - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Corbus Pharmaceuticals Holdings Inc. stock price move sharplyPotential Rocket List - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Corbus Pharmaceuticals Holdings Inc. stock performs during market volatilityLow Risk ROI Maximization - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

(CRBP) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 09, 2025
pulisher
Jul 09, 2025

Bullish Sentiment Across The Cannabis SpaceCheck Full Movers For July 9, 2025 - Benzinga

Jul 09, 2025
pulisher
Jul 07, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Jul 07, 2025
pulisher
Jun 30, 2025

Corbus begins multiple ascending dose portion of CRB-913 obesity trial - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Corbus Pharmaceuticals Holdings, Inc.(NasdaqCM:CRBP) dropped from Russell Small Cap Completeness Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

How the (CRBP) price action is used to our Advantage - news.stocktradersdaily.com

Jun 29, 2025
pulisher
Jun 27, 2025

Cannabis Stock Movers For June 27, 2025 - Benzinga

Jun 27, 2025
pulisher
Jun 25, 2025

Corbus Pharmaceuticals Initiates PD-1 Combination Cohort in Phase 1 Study of CRB-701 for Solid Tumors - Quiver Quantitative

Jun 25, 2025
pulisher
Jun 25, 2025

Corbus Cancer Drug Shows Promise: New Phase 1 Trial Combines Novel Nectin-4 ADC With Keytruda - Stock Titan

Jun 25, 2025
pulisher
Jun 24, 2025

Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium - GlobeNewswire

Jun 24, 2025
pulisher
Jun 17, 2025

Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data? - Seeking Alpha

Jun 17, 2025
pulisher
Jun 15, 2025

Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) PT at $50.88 - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Buys 7,207 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 13, 2025
pulisher
Jun 08, 2025

11,027 Shares in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Bought by Two Sigma Advisers LP - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

(CRBP) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Has $341,000 Stake in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Dermatomyositis Market Predicted to See Upsurge Through 2034, - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Investments LP Purchases 91,205 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Deutsche Bank AG - Defense World

Jun 04, 2025
pulisher
May 29, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Millennium Management LLC - Defense World

May 29, 2025
pulisher
May 29, 2025

Northern Trust Corp Acquires 11,400 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 29, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Makes New Investment in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

May 27, 2025
pulisher
May 23, 2025

3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies - Zacks Investment Research

May 23, 2025
pulisher
May 22, 2025

Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Corbus Pharmaceuticals CEO Set to Reveal Latest Corporate Strategy at Major Jefferies Healthcare Conference - Stock Titan

May 22, 2025

Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):